Die Rolle der nicht-alkoholischen Fettlebererkrankung für den gewebespezifischen Energiestoffwechsel und die Insulinsensitivität vor und nach Adipositaschirurgie – Hans-Christian-Hagedorn-Projektförderung 2021 – eine Kurzübersicht der Geförderten Sabine Kahl

• Literatur

• 1 Kahl S, Pützer J, Roden M. Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis. Semin Liver Dis 2021;
• 2 Younossi ZM, Henry L. Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma. JHEP Rep 2021; 3 (04) 100305
• 3 Younossi ZM, Tampi RP, Racila A. et al. Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S. Diab Care 2020; 43 (02) 283-289
• 4 Hernández E, Kahl S, Seelig A. et al. Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance. J Clin Invest 2017; 127 (02) 695-708
• 5 Sarabhai T, Kahl S, Szendroedi J. et al. Monounsaturated fat rapidly induces hepatic gluconeogenesis and whole-body insulin resistance. JCI Insight 2020; 5 (10) e134520
• 6 Koliaki C, Szendroedi J, Kaul K. et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab 2015; 21 (05) 739-746
• 7 Gancheva S, Koliaki C, Jelenik T. et al. Loss of Adaptation of Hepatic Oxidative Capacity in Patients with Type 2 Diabetes and Non-Alcoholic Steatohepatitis (NASH). 77th Scientific Sessions of the American Diabetes Association. San Diego, CA, USA. Diabetes 2017; 66 (Suppl. 01) A90
• 8 Targher G, Corey KE, Byrne CD. et al. The complex link between NAFLD and type 2 diabetes mellitus – mechanisms and treatments. Nat Rev Gastroenterol Hepatol 2021; 18 (09) 599-612
• 9 Kahl S, Gancheva S, Straßburger K. et al. Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial. Diab Care 2020; 43 (02) 298-305
• 10 Jans A, Näslund I, Ottosson J. et al. Duration of type 2 diabetes and remission rates after bariatric surgery in Sweden 2007–2015: A registry-based cohort study. PLoS Med 2019; 16 (11) e1002985
• 11 Gancheva S, Ouni M, Jelenik T. et al. Dynamic changes of muscle insulin sensitivity after metabolic surgery. Nat Commun 2019; 10 (01) 4179
• 12 Gancheva S, Jelenik T, Álvarez-Hernández E. et al. Interorgan Metabolic Crosstalk in Human Insulin Resistance. Physiol Rev 2018; 98 (03) 1371-1415